PIPERACILLIN

Post-LOE

piperacillin sodium

Pfizer

ANDAINJECTIONINJECTABLE

Approved

Nov 2003

Lifecycle

Post-LOE

Competitive Pressure

30/100

Clinical Trials

Data completeness

2/8 — Basic

Drug data last refreshed 20h ago

Mechanism of Action

Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.

Indications

Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.

Clinical Trials (20)

NCT05981079Phase 4Unknown

Model-based Dose Versus Empirical Dose of Piperacillin/Tazobactam in Preterm Neonates With Late-onset Sepsis.

Started Jul 2023

NCT03583333Phase 3Completed

Imipenem/Cilastatin/Relebactam (MK-7655A) Versus Piperacillin/Tazobactam in Participants With Hospital-Acquired or Ventilator-Associated Bacterial Pneumonia (MK-7655A-016)

Started Sep 2018

274 enrolled

Hospital-Acquired Bacterial PneumoniaVentilator-Associated Bacterial Pneumonia

NCT03441529Phase 1Completed

A Crossover Study to Assess the Effect of Intravenous Infusion of Piperacillin/Tazobactam on the Pharmacokinetics of Orally Administered Lumicitabine (JNJ-64041575) in Healthy Adult Participants

Started Feb 2018

18 enrolled

Healthy

NCT03269994Phase 3Completed

Does Cefoxitin or Piperacillin-Tazobactam Prevent Postoperative Surgical Site Infections After Pancreatoduodenectomy?

Started Nov 2017

967 enrolled

Pancreatic CancerPancreas CancerPancreatic Diseases

NCT02753946Phase 2/3Completed

Safety and Efficacy of ZTI-01 (IV Fosfomycin) vs Piperacillin/Tazobactam for Treatment cUTI/AP Infections

Started Apr 2016

465 enrolled

Urinary Tract Infection SymptomaticAcute PyelonephritisUrinary Tract Infection Complicated

Worked on PIPERACILLIN at Pfizer? Share your interview experience or compensation data (+7 days Pro)

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.